Pfaar, O., Klimek, L., & Gerth van Wijk, R. (2015). Clinically relevant outcome measures for new pharmacotherapy, allergen avoidance and immunotherapy trials in allergic rhinoconjunctivitis. Current opinion in allergy and clinical immunology, 15(3), . https://doi.org/10.1097/ACI.0000000000000164
Chicago Style (17th ed.) CitationPfaar, Oliver, Ludger Klimek, and Roy Gerth van Wijk. "Clinically Relevant Outcome Measures for New Pharmacotherapy, Allergen Avoidance and Immunotherapy Trials in Allergic Rhinoconjunctivitis." Current Opinion in Allergy and Clinical Immunology 15, no. 3 (2015). https://doi.org/10.1097/ACI.0000000000000164.
MLA (9th ed.) CitationPfaar, Oliver, et al. "Clinically Relevant Outcome Measures for New Pharmacotherapy, Allergen Avoidance and Immunotherapy Trials in Allergic Rhinoconjunctivitis." Current Opinion in Allergy and Clinical Immunology, vol. 15, no. 3, 2015, https://doi.org/10.1097/ACI.0000000000000164.